George Kirk

Global Franchise Head @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2025 — Present

Global Franchise Head @AstraZeneca

View department →

Cambridge, GB

EDUCATION

1988 — 1995

University of Strathclyde

BSc ; PhD, Chemistry

SKILLS

ChromatographyBiotechnologyCross-Functional Team LeadershipValidationMedicinal ChemistryCROLife SciencesChemistryGlpOncologyHplcRegulatory AffairsLifesciencesRegulatory SubmissionsPharmaceutical IndustryTechnology TransferGmpClinical DevelopmentR&DPharmaceuticsDrug DiscoveryDrug DevelopmentGcpAnalytical ChemistryProject ManagementClinical TrialsOrganic Chemistry

ABOUT GEORGE KIRK

Vice President and Global Franchise Head in Oncology at AstraZeneca with ~30 years of experience translating science into impact for patients. I lead end-to-end clinical strategy and development from first-in-human through registrational studies across solid tumours and paediatrics, spanning targeted therapies, antibody–drug conjugates, and small molecules. Guided by two principles—following the science and doing the right thing for patients—I partner across R&D, medical, regulatory, and commercial to shape portfolio strategy and deliver rigorous evidence, patient centric design, and high-quality execution. I focus on scientific rigor, ethical decision-making, operational excellence, and collaborative leadership that accelerates responsible progress. I’m motivated by the privilege of serving patients and teams and always open to connect on advancing oncology development, with a particular focus on paediatrics.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

George Kirk — Global Franchise Head at AstraZeneca in Cambridge, GB | Unifers